These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11120990)

  • 1. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.
    Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2001 Jan; 45(1):327-30. PubMed ID: 11120990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates.
    Arikan S; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3084-7. PubMed ID: 12183278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.
    Martos AI; Romero A; González MT; González A; Serrano C; Castro C; Pemán J; Cantón E; Martín-Mazuelos E
    Med Mycol; 2010 Sep; 48(6):858-61. PubMed ID: 20144131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A colorimetric and spectrophotometric method for in vitro susceptibility testing of Aspergillus species against caspofungin.
    Te Dorsthorst DT; Zwaaftink RB; Rijs AJ; Meletiadis J; Verweij PE
    Med Mycol; 2007 Jun; 45(4):351-5. PubMed ID: 17510858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
    Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2002 Jan; 46(1):245-7. PubMed ID: 11751145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
    Espinel-Ingroff A
    J Clin Microbiol; 2003 Jan; 41(1):403-9. PubMed ID: 12517880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of minimum inhibitory and minimum effective concentration values for the detection of in vitro susceptibilities of Aspergillus species against caspofungin].
    Ozkütük A; Metin DY; Ergon C; Yücesoy M; Hilmioğlu PS
    Mikrobiyol Bul; 2007 Apr; 41(2):285-90. PubMed ID: 17682716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.
    Yekutiel A; Shalit I; Shadkchan Y; Osherov N
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3279-83. PubMed ID: 15328085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.
    Shalit I; Shadkchan Y; Samra Z; Osherov N
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1416-8. PubMed ID: 12654681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
    Perea S; Gonzalez G; Fothergill AW; Kirkpatrick WR; Rinaldi MG; Patterson TF
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3039-41. PubMed ID: 12183266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.
    Odds FC; Motyl M; Andrade R; Bille J; Cantón E; Cuenca-Estrella M; Davidson A; Durussel C; Ellis D; Foraker E; Fothergill AW; Ghannoum MA; Giacobbe RA; Gobernado M; Handke R; Laverdière M; Lee-Yang W; Merz WG; Ostrosky-Zeichner L; Pemán J; Perea S; Perfect JR; Pfaller MA; Proia L; Rex JH; Rinaldi MG; Rodriguez-Tudela JL; Schell WA; Shields C; Sutton DA; Verweij PE; Warnock DW
    J Clin Microbiol; 2004 Aug; 42(8):3475-82. PubMed ID: 15297486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.
    Pfaller MA; Marco F; Messer SA; Jones RN
    Diagn Microbiol Infect Dis; 1998 Apr; 30(4):251-5. PubMed ID: 9582584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New methods to assess susceptibilities of Aspergillus isolates to caspofungin.
    Imhof A; Balajee SA; Marr KA
    J Clin Microbiol; 2003 Dec; 41(12):5683-8. PubMed ID: 14662961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.
    Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2007 Mar; 51(3):881-7. PubMed ID: 17145783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of caspofungin against Aspergillus terreus.
    Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Fallani S; Manso E; Pisa E; Giannini D; Novelli A; Cassetta MI; Mazzei T; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5133-5. PubMed ID: 16304185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    Diagn Microbiol Infect Dis; 2010 May; 67(1):56-60. PubMed ID: 20207095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.
    Kontoyiannis DP; Lewis RE; Osherov N; Albert ND; May GS
    J Antimicrob Chemother; 2003 Feb; 51(2):313-6. PubMed ID: 12562696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
    Espinel-Ingroff A
    J Clin Microbiol; 1998 Oct; 36(10):2950-6. PubMed ID: 9738049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.